Evidence map›Paper›PMID 31434721›Full record

ArticleJournal of clinical microbiology2019

Clinical and Molecular Characteristics of Klebsiella pneumoniae Isolates Causing Bloodstream Infections in Japan: Occurrence of Hypervirulent Infections in Health Care.

Sohei Harada, Kotaro Aoki, Shungo Yamamoto, Yoshikazu Ishii, Noritaka Sekiya, Hanako Kurai, Keiichi Furukawa, Asako Doi, Kentaro Tochitani, Kenji Kubo and 17 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 2 syntheses or guidelines pooled it, 118 citations in OpenAlex.

  1. Association of Klebsiella pneumoniae sequence type 11 but not other virulence factors with patient mortality: a systematic review and meta-analysis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Phenotypic screening of hypervirulentMicrobiology spectrum · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Carriage of hypervirulent and ESBL-producingApplied and environmental microbiology · 2026
    Article
  11. Article
  12. Hypervirulent and Drug-ResistantInternational journal of general medicine · 2026
    Review
  13. Overcoming phagocytosis resistance of hypervirulentMicrobial cell (Graz, Austria) · 2026
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Whole Genome Sequencing ofAntibiotics (Basel, Switzerland) · 2025
    Article
  19. Article
  20. Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 20 institutions in 1 country.

Sohei HaradaDepartment of Infectious Diseases, Fujita Health University School of Medicine, Toyoake, Aichi, Japan haradas-tky@umin.ac.jp.
Kotaro AokiDepartment of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan.
Shungo YamamotoDepartment of Infectious Diseases, Kyoto City Hospital, Kyoto, Japan.
Yoshikazu IshiiDepartment of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan.
Noritaka SekiyaDepartment of Infection Prevention and Control, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Hanako KuraiDivision of Infectious Diseases, Shizuoka Cancer Center Hospital, Nagaizumi, Shizuoka, Japan.
Keiichi FurukawaDivision of Infectious Diseases, St. Luke's International Hospital, Tokyo, Japan.
Asako DoiDepartment of Infectious Diseases, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
Kentaro TochitaniDepartment of Infectious Diseases, Kyoto City Hospital, Kyoto, Japan.
Kenji KuboDepartment of Infectious Diseases, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.
Yukihiro YamaguchiDepartment of infectious diseases, Kenwakai Otemachi Hospital, Kitakyushu, Fukuoka, Japan.
Masashi NaritaDepartment of Medicine, Ohta Nishinouchi General Hospital, Koriyama, Fukushima, Japan.
Shinya KamiyamaDepartment of Clinical Laboratory Medicine and Infectious Diseases, Kurashiki Central Hospital, Kurashiki, Okayama, Japan.
Jun SuzukiDivision of General Internal Medicine, National Hospital Organization Nagoya Medical Center, Nagoya, Aichi, Japan.
Takahiko FukuchiDivision of Infectious Disease Therapeutics, Department of Microbiology and Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Yoshiaki GuDepartment of Infectious Diseases, Tohoku University Hospital, Sendai, Miyagi, Japan.
Keiji OkinakaDivision of General Internal Medicine, National Cancer Center Hospital, Tokyo, Japan.
Soichi ShiikiDivision of Infectious Diseases, Okinawa Chubu Hospital, Uruma, Okinawa, Japan.
Kayoko HayakawaDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Natsuo TachikawaDepartment of Infectious Diseases, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan.
Kei KasaharaCenter for Infectious Diseases, Nara Medical University, Kashihara, Nara, Japan.
Tadahiro NakamuraDepartment of Internal medicine, Japan Community Health care Organization Osaka Hospital, Osaka, Japan.
Kyoko YokotaDepartment of General Internal Medicine, Faculty of Medicine, Kagawa University, Takamatsu, Kagawa, Japan.
Masanari KomatsuDivision of General Medicine, Kagoshima Seikyo Hospital, Kagoshima, Japan.
Misaki TakamiyaDepartment of infectious diseases, Hamamatsu Medical Center, Hamamatsu, Shizuoka, Japan.
Kazuhiro TatedaDepartment of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan.
Yohei DoiDepartment of Infectious Diseases, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Toho University · JPKyoto City Hospital · JPOkinawa Prefectural Chubu Hospital · JPFujita Health University · JPHamamatsu Medical Center · JPJapan Community Healthcare Organization · JPJapanese Foundation For Cancer Research · JPJapanese Red Cross Society Wakayama Medical Center · JPKagawa University · JPKagoshima City Hospital · JPKobe City Medical Center General Hospital · JPKobe University · JPKurashiki Central Hospital · JPNagoya Medical Center · JPNara Medical University · JPNational Center for Global Health and Medicine · JPShizuoka Cancer Center · JPSt. Luke's International Hospital · JPTohoku University Hospital · JPTokyo Metropolitan Komagome Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although hypervirulent

Indexed as

AgedAged, 80 and overAnti-Bacterial AgentsBacteremiabeta-LactamasesCross InfectionCross-Sectional StudiesFemaleGenome, BacterialHospitalsHumansJapanKlebsiella InfectionsKlebsiella pneumoniaeMaleVirulenceAnti-Bacterial Agentsbeta-Lactamasesbloodstream infectiondisseminated infectionhypervirulent Klebsiella pneumoniaewhole-genome sequencing

Identifiers

PMID31434721
PMCPMC6812994
OpenAlexW2969844487

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.